The February earnings season can often bring some big moves from S&P/ASX 200 (INDEXASX: XJO) shares. When a company releases its results, it is one of the few opportunities for investors to get a snapshot of the company's financial health.
Management's outlook for the year ahead can also set expectations for the full year results in 6 months' time.
With that in mind, here's a closer look at 4 ASX 200 shares are up 25% or more this month after reporting results.
Breville Group Ltd (ASX: BRG)
The Breville share price has rocketed 28.33% higher so far this month. It's no surprise that a strong earnings result was the big factor in the move.
Breville shares rocketed to a new all-time high after reporting a $67.4 million net profit on total revenue of $760 million.
The Aussie kitchenware maker has been one of the strongest performing ASX 200 shares in recent times. With a strong outlook ahead for FY 2020, I wouldn't bet against Breville going higher this year.
Pinnacle Investment Management Group Ltd (ASX: PNI)
Pinnacle shares jumped in early February after a solid half-year result. The investment manager's profit surged 36.6% to $13.8 million with a 6.6 cents per share interim dividend.
Pinnacle now boasts funds under management of $61.6 billion, an increase of 13% on the prior corresponding period.
The ASX 200 investment group's shares are now up 25.26% this month and could be on the move in 2020.
IDP Education Ltd (ASX: IEL)
The IDP Education share price has surged 25.21% higher in February including a surge of 28% on February 12.
A strong half-year result was headlined by a 20% increase in revenue and 53% jump in earnings before interest, tax, depreciation and amortisation. The group reported a 42% increase in earnings per share to 23.4 cents.
Maybe the biggest factor, however, was a 37% increase in the ASX 200 education group's dividend to 16.5 cents per share.
Avita Medical Ltd (ASX: AVH)
The Avita Medical share price will open at a 52-week high of $0.85 per share after a 25% gain in February.
Avita Medical is continuing to push into the lucrative US medical technology sector. With a strong balance and big potential upside from its RECELL technology, Avita Medical shares could be going higher this year.
